The Ultimate Guide To The Kedplasma 360 Questionnaire In 2026
Note: This guide focuses specifically on the digital health screening and medical history evaluation protocol utilized by Kedplasma centers, commonly referred to as the Kedplasma 360 questionnaire.
Navigating the plasma donation process requires stringent adherence to health, safety, and regulatory frameworks. As the biopharmaceutical landscape evolves through 2026, plasma collection centers like Kedplasma have optimized their donor screening workflows. At the center of this technological and clinical advancement is the Kedplasma 360 questionnaire—a comprehensive digital pre-donation assessment tool designed to safeguard both the donor and the plasma supply chain. Understanding how this system operates, what medical criteria it evaluates, and how to complete it efficiently ensures a smooth, safe, and successful donation experience.
Understanding the Evolution of Donor Screening Protocols
Plasma donation is a vital biological manufacturing input used to create therapies for rare diseases, immune deficiencies, and emergency trauma care. Because plasma is fractionated and administered to vulnerable patient populations, regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the Plasma Protein Therapeutics Association (PPTA) mandate rigorous screening protocols.
The Kedplasma 360 platform represents a generational shift from legacy paper-based health histories to an integrated, cloud-connected digital intake portal. Donors interact with this questionnaire via dedicated kiosk terminals at donation centers or through optimized mobile pre-check applications. By standardizing the collection of medical history, current medication usage, travel history, and lifestyle factors, the system minimizes human error and significantly accelerates the physical evaluation lane.
Core Objectives of the 360 Screening Architecture
- Risk Mitigation: Identifying acute or chronic medical conditions that could compromise the donor's physiological stability during phlebotomy.
- Pathogen Exclusion: Screening out individuals who have engaged in high-risk behaviors or traveled to regions with active outbreaks of vector-borne or transfusion-transmitted infections.
- Component Quality Assurance: Ensuring that recent dietary habits, hydration levels, and prescription drug intakes align with federal protein and plasma composition safety thresholds.
- Operational Efficiency: Reducing wait times on the donor floor by processing baseline medical queries before physical vitals and hematocrit testing occur.
Key Sections and Clinical Categories within the Questionnaire
The Kedplasma 360 questionnaire is logically structured into distinct clinical domains. Each section targets specific health parameters that dictate donor eligibility for a given day or deferral period.
Personal Identification and Demographics
This initial phase verifies baseline data, matching the donor's government-issued photo identification, social security or donor ID number, and current residential address. Maintaining accurate demographic records is a regulatory necessity for trace-back investigations if any post-donation viral markers are detected.
Current Health and Symptom Check
Donors must disclose how they feel on the day of donation. The questionnaire explicitly probes for acute symptoms:
- Recent fever, chills, or unexplained fatigue.
- Active respiratory infections, coughing, or sinus congestion.
- Open wounds, recent surgical procedures, or active skin infections near the venipuncture site.
- Unexplained weight loss or night sweats.
Medication and Treatment Review
Certain pharmaceutical agents persist in plasma and can cause severe adverse reactions in recipients, particularly pregnant women or individuals with specific organ conditions. The Kedplasma 360 system cross-references active drug classes against an up-to-date exclusion database.
| Medication Category | Clinical Impact on Plasma Donation | Deferral Status |
|---|---|---|
| Teratogenic Drugs (e.g., Accutane, Finasteride) | Can cause severe birth defects if transferred via plasma derivatives. | Temporary Deferral (ranging from 1 month to permanent depending on the specific drug) |
| Anticoagulants (e.g., Warfarin, Eliquis) | Interferes with blood clotting and increases post-phlebotomy hematoma risk. | Permanent or Temporary Deferral (pending medical clearance) |
| Antibiotics (Active Infection) | Indicates an active bacterial infection being treated by the body. | Temporary Deferral until treatment is completed and symptoms resolve |
| Live Vaccines (e.g., MMR, Varicella) | Potential circulation of live attenuated viral particles in the bloodstream. | Temporary Deferral (typically 2 to 4 weeks post-immunization) |
Travel and Exposure History
Geographic epidemiology plays a massive role in screening. The questionnaire queries recent international travel, particularly to regions endemic for malaria, Zika virus, Variant Creutzfeldt-Jakob Disease (vCJD), and other regional pathogens that standard laboratory nucleic acid testing (NAT) may not immediately capture.
Spidergap - Our 360 feedback questionnaire standard template | PDF
Step-by-Step Guide to Completing the Kedplasma 360 Questionnaire
Successfully navigating the assessment requires honesty, precision, and preparation. Follow this structured walkthrough to ensure compliance and avoid unnecessary deferrals.
- Pre-Hydration and Nutritional Prep: Before logging into the questionnaire, ensure you have consumed adequate water and iron-rich meals. Dehydration or low protein levels can trigger physical deferrals regardless of questionnaire answers.
- Accessing the Portal: Log into the Kedplasma 360 kiosk or mobile companion application using your unique donor credentials.
- Reviewing Prior History: If you are a returning donor, the system will prompt you to confirm your previous baseline and report any changes since your last visit. Answer honestly regarding any new tattoos, piercings, medical diagnoses, or sexual health risk factors.
- Answering Honestly and Consistently: Never attempt to conceal medical conditions or travel history. The screening questions are designed for safety; answering inaccurately can lead to permanent bans or compromise patient safety.
- Review and Electronic Signature: Verify all answers before final submission. The system generates a digital timestamped summary that the attending phlebotomist and medical staff review during your physical vitals assessment.
Expert Operational Tip: Arrive at the center with a complete, accurate list of all current prescription medications, exact dosages, and recent travel dates written down. This prevents hesitation or inaccuracies when the digital kiosk times out during input.
Common Reasons for Deferral and How to Handle Them
Even with meticulous preparation, donors occasionally encounter temporary or permanent deferrals based on their questionnaire responses or subsequent physical screenings. Understanding these triggers helps manage expectations.
- Temporary Deferrals: Linked to acute illnesses, recent tattooing or body piercing performed in unlicensed or uncertified state facilities, short-term antibiotic use, or temporary travel to malaria-endictive zones. Once the mandatory waiting period expires, you may return and clear the questionnaire.
- Permanent Deferrals: Triggered by a history of certain infectious diseases (such as HIV, Hepatitis B, or Hepatitis C), specific neurological conditions, or prolonged residency in countries with high vCJD exposure risks. These decisions are final and protect the integrity of the global plasma supply.
Frequently Asked Questions About the Kedplasma 360 Questionnaire
What is the primary purpose of the Kedplasma 360 questionnaire?
The Kedplasma 360 questionnaire is a digital screening tool used to evaluate a donor's medical history, current health, travel background, and medication use to ensure the safety of both the donor and the resulting plasma products. It replaces legacy paper forms with a streamlined, secure electronic intake process.
Do I have to complete the questionnaire every single time I donate?
Yes, a health screening questionnaire must be completed prior to every single plasma donation. Because health status, medication regimens, and travel exposures can change rapidly from week to week, federal regulations require an up-to-date health assessment on the exact day of donation.
What happens if I accidentally make a mistake on my digital questionnaire answers?
If you realize you provided an incorrect answer while completing the questionnaire on the kiosk or app, notify a Kedplasma staff member immediately. Center medical personnel can flag your electronic profile, review the discrepancy with you, and correct the record before your physical vitals and blood draw take place.
Are my personal health answers kept confidential?
Yes, all data entered into the Kedplasma 360 system is strictly confidential and protected under federal healthcare privacy standards, including HIPAA regulations. Access is restricted to authorized medical and operational staff necessary for clearing your donation eligibility.
Can I complete the Kedplasma 360 questionnaire at home before arriving?
Depending on your regional center's specific software rollout and regulatory approvals, certain pre-check phases or update prompts may be accessible via mobile applications. However, the final official attestation and health verification must be completed in-center under the supervision of qualified medical staff.
Conclusion and Next Steps
The Kedplasma 360 questionnaire stands as a cornerstone of modern, safe, and efficient plasma collection. By leveraging digital health evaluations, Kedplasma ensures that every step of the donation pipeline adheres to elite clinical and regulatory benchmarks. For regular donors and newcomers alike, approaching this digital assessment with transparency, proper hydration, and accurate medical knowledge ensures a seamless journey toward saving lives through plasma donation. To take the next step, schedule your appointment at your nearest Kedplasma center and prepare your donor profile today.
